AI assistant
Bafna Pharmaceuticals Limited AGM Information 2021
62471_rns_2021-08-14_1d3440aa-aced-4f44-a2de-25423f1c97d9.pdf
AGM Information
Open in viewerOpens in your device viewer
BAFNA PHARMACEUTICALS LTD.,
www.bafnapharma.com
Date: 14th August 2021
| ListingDepartment | ListingDepartment | |
|---|---|---|
| BSELimited | ExchangeofLimitedNationalStockIndia | |
| P J Towers | ExchangePlaza,BandraKurlaComplex, | |
| DalalStreet,Mumbai400001- | Bandra(E),Mumbai400051- | |
| Securitycode532989: | Symbol:BAFNAPH | |
| SecurityIDBAFNAPHARM: | Series:EQ |
Dear Sir,
Sub.:- Proceedings of 26th Annual General Meeting held on 14th Aug 2021
Ref.:- Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Please be informed that the 26th AGM of the Company was held on 14th August 2021 through Video Conferencing ("VC")/ Other Audio Visual Means ("OAVM") at 11.00 a.m. 1ST.
In this regard please find attached the summary of the proceedings of the AGM of the Company.
The voting results of the 26th Annual General Meeting of the Company along with the Scrutinizer report will be shared shortly.
The 26th Annual General Meeting of the Company was concluded at 12.00 Noon 1ST
We request you to take the above information on your record
Thanking you.
For BAFNA PHARMACEUTICALS LIMITED
,-·°'°' Jitendra Kumar Pal Company Secretary
BAFNA PHARMACEUTICALS LTD.,
www.bafnapharma.com
Sub: Proceedings of 26th Annual General Meeting of the Company
In Compliance with Regulation 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the proceedings of 26th Annual General Meeting ('AGM') of the members of Bafna Pharmaceuticals Limited ('the Company'), held today i.e. Saturday, August 14, 2021 at 11 :00 A.M 1ST through Video Conferencing (VC) I Other Audio Visual Means (OAVM) and the meeting concluded at 12:00 Noon 1ST.
Chairperson of the Company Ms. S. Hemalatha welcomed the Shareholders, who were participating in the Meeting through Video Conferencing (VC) I Other Audio Visual Means (OAVM) and she has also briefed them about certain important points regarding video conferencing.
In compliance with the provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014, as amended and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and applicable provisions of the Companies Act, 2013 read with circulars, issued by Ministry of Corporate Affairs dated May 5, 2020, April 13, 2020, April 8, 2020 and SEBI Circular dated May 12, 2020, the Company has provided the facility to members, to exercise their right to vote, by electronic means on resolutions proposed to be passed at the AGM, either through Remote E-voting or E-voting during AGM.
The remote e-voting facility was provided by the Company from Wednesday, August 11, 2021 at 10:00 AM 1ST to Friday, August 13, 2021 at 5:00 PM 1ST to all the members of the Company, who were holding shares (either in physical form or dematerialized form) as on the cut-off date i.e. Saturday, August 7, 2021.
The members of the Company were informed that "members attending the AGM, through Video Conferencing (VC) I Other Audio Visual Means (OAVM), who have not cast their votes by remote e-voting, can cast their vote through e-voting during the AGM.
BAFNA PHARMACEUTICALS LTD.,
All efforts feasible under the circumstances have indeed been made by the Company to enable members to participate and vote on the item being considered in the meeting, after duly complying with the mechanism provided in MCA circular dt May 5, 2020, April 13, 2020 & April 8, 2020 along with other provisions of the Act and Rules.
Ms. S. Hemalatha, Chairperson of the Board, chaired the meeting through Video Conferencing (VC} I Other Audio Visual Means (OAVM}. All the Directors except (Mrs. R. Chitra}, Authorised Representatives of Statutory & Secretarial Auditors and Chief Financial Officer of the Company had also joined the meeting and welcomed & introduced all the dignitaries with the shareholders.
Since the quorum of the meeting was present, the Chairperson called the meeting to order and conducted the proceedings of the meeting through Video Conferencing (VC} I Other Audio Visual Means (OAVM}.
she has further informed that M/s R. Sathyanaryanan & Co, Statutory Auditors of the Company and M/s. Balu Sridhar, Partner of M/s. A.K.Jain & Associates, Secretarial Auditors of the Company, have given the Audit Reports with qualifications, observations or comments on financial transactions or matters, which do not have any adverse effect on the functioning of the Company, for which Management's explanation has been given, with the permission of members, the Auditors Reports as well as Directors Report of the Company, have been taken as read.
As the Meeting was convened through Video Conferencing (VC} I Other Audio Visual Means (OAVM}, so, the following Resolutions had already been put to vote through remote e-voting thus the requirement to propose and second was not applicable:
| SNo. | Particularsofresolutions | ofResolutionTvoe |
|---|---|---|
| ORDINARY | BUSINESS | |
| 1 | receive,considerandadopttheAuditedTo | Ordinary |
| CompanytheFinancialStatementsofthefor | Resolution | |
| 31,alongfinancialendedMarch2021yearon | ||
| ReportsoftheAuditorsandDirectorswith | ||
| thereon. |
www.bafnapharma.com
| SPECIALBUSINESS | ||
|---|---|---|
| 2 | ofAppointmentofMs.S.Regularisation(DIN:02714329)Whole-TimeHemalathaasDirector | OrdinaryResolution |
| 3 | RegularisationAppointmentofAkilaCofMrs.(DIN:07590312)(NonRajuDirectorasaIndependent)Executive& Non- | OrdinaryResolution |
| 4 | RegularisationAppointmentofofMrs.RavichandranChitra(DIN:07749125)asanIndependentNonExecutiveDirector | OrdinaryResolution |
| 5 | RegularizationofAppointmentofMr.Atul(DIN:07645130)(NonSachdevaDirectorasaIndependent)Executive& Non- | OrdinaryResolution |
| 6 | & CO,AppointmentM/s.N SIVASHANKARAN{FRN100662),CostAccountantsCostasAuditor | OrdinaryResolution |
The members were further informed that Mr Pankaj Mehta, Partner of A.K.Jain & Associates, Company Secretary in Practice, was appointed as Scrutinizer for the purpose of scrutinizing the e-voting process in a fair and transparent manner. Ms. S. Hemalatha, Chairperson of the meeting, authorized Shri. Jitendra Kumar Pal , Company Secretary to receive the Scrutinizers' Report/Registers who shall countersign the same.
The Company Secretary further informed the members that the results of e-voting shall be disseminated to the Stock Exchanges at www.bseindia.com & www.nseindia.com and will also be displayed on the website of CDSL i.e www.evolingindia.com, the e-voting agency, on the Company's website at www.bafnapharma.com.
Ms. S. Hemalatha, Chairperson gave her speech to the shareholders.
Shri Jitendra Kumar Pal, Company Secretary of the Company, further informed that the members were given an opportunity to send their queries and questions, in advance at [email protected].
Thereafter, the Company Secretary informed, that the members, who had not cast their vote already through Remote e-voting, may cast their vote by
www.bafnapharma.com
going to the e-voting platform and the same has been· kept open till 12.00 Noon.
The Company Secretary proposed a vote of thanks to the Chair & the shareholders and the meeting concluded.
This is for your information and records please.
For Bafna Pharmaceuticals Limited
Jitendra?r Pal Company Secretary
